SCHEMBL22762464

SCHEMBL22762464

CC(C)(C=O)c1csc(NSC2CC2)n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ATAD2 Q6PL18 1/20 0.41
▸ LMNA P02545 3/20 0.35
▸ SMN1; SMN2 Q16637 4/20 0.35
▸ TAS1R3 Q7RTX0 1/20 0.35
▸ TAS1R1 Q7RTX1 1/20 0.35
▸ TAS1R2 Q8TE23 1/20 0.35
▸ KMT2A Q03164 5/20 0.34
▸ NPC1 O15118 5/20 0.33
▸ MEN1 O00255 4/20 0.33
▸ RAB9A P51151 4/20 0.33
▸ CCR4 P51679 2/20 0.33
▸ TMIGD3 P0DMS9 1/20 0.33
▸ ADORA1 P30542 1/20 0.33
▸ KDM4E B2RXH2 2/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ MAPT P10636 2/20 0.33
▸ MAPK1 P28482 2/20 0.33
▸ HPGD P15428 1/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33
▸ GAA P10253 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21387600 0.70 CTPS1 (0.31) —
SCHEMBL21076824 0.70 CTPS1 (0.48) ATAD2LMNASMN1; SMN2KMT2ANPC1
SCHEMBL21076850 0.68 LCK (0.39) ATAD2LMNASMN1; SMN2KMT2ANPC1
SCHEMBL21077100 0.67 CTPS1 (0.48) ATAD2LMNASMN1; SMN2KMT2ANPC1
SCHEMBL21076996 0.66 CTPS1 (0.53) ATAD2SMN1; SMN2KMT2ANPC1MEN1
SCHEMBL77452 0.62 CCR4 (0.51) ATAD2LMNASMN1; SMN2TAS1R3TAS1R1
SCHEMBL21076997 0.61 RAB9A (0.34) ATAD2SMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL2441700 0.60 ATAD2 (0.40) ATAD2LMNASMN1; SMN2TAS1R3TAS1R1
SCHEMBL21181532 0.59 KDM4E (0.45) LMNAKMT2AMEN1KDM4EALDH1A1
SCHEMBL15899105 0.59 CCR4 (0.56) ATAD2LMNASMN1; SMN2TAS1R3TAS1R1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020245665-A1 N-(4-(5-CHLOROPYRIDIN-3-YL)PHENYL)-2-(2-(CYCLOPROPANESULFONAMIDO)PYRIMIDIN-4-YL) BUTANAMIDE DERIVATIVES AND RELATED COMPOUNDS AS HUMAN CTPS1 INHIBITORS FOR THE TREATMENT OF PROLIFERATIVE DISEASES STEP PHARMA S.A.S. (FR) 2020-12-10 — — WO disclosed
Send feedback